ISRG
Intuitive Surgical, Inc.NASDAQHealthcare$452.07-2.67%ClosedMarket Cap: $160.54B
As of 2026-04-06
Valuation
P/E (TTM)
56.21
PEG
2.45
P/B
9.00
P/S
15.95
EV/EBITDA
43.47
DCF Value
$104.66
FCF Yield
1.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
66.0%
Operating Margin
29.3%
Net Margin
28.4%
ROE
16.4%
ROA
14.1%
ROIC
13.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $2.87B | 66.4% | $864.3M | $794.8M | $2.21 | — |
| FY 2025 | $10.06B | 66.0% | $2.95B | $2.86B | $7.87 | — |
| Q3 2025 | $2.51B | 66.4% | $759.7M | $704.4M | $1.95 | — |
| Q2 2025 | $2.44B | 66.3% | $743.4M | $658.4M | $1.81 | — |
| Q1 2025 | $2.25B | 64.7% | $578.1M | $698.4M | $1.92 | — |
| Q4 2024 | $2.41B | 68.0% | $734.9M | $685.7M | $1.88 | — |
| FY 2024 | $8.35B | 67.5% | $2.35B | $2.32B | $6.42 | — |
| Q3 2024 | $2.04B | 67.4% | $577.3M | $565.1M | $1.56 | — |
| Q2 2024 | $2.01B | 68.3% | $567.3M | $526.9M | $1.46 | — |
| Q1 2024 | $1.89B | 65.9% | $469.4M | $544.9M | $1.51 | — |
| Q4 2023 | $1.93B | 66.2% | $450.2M | $606.2M | $1.69 | — |
| FY 2023 | $7.12B | 66.4% | $1.77B | $1.80B | $5.03 | — |